Some investors asked on the investor interaction platform: did the company increase its R & D investment last year? What is the company’s main R & D direction?
Tianjin Ringpu Bio-Technology Co.Ltd(300119) ( Tianjin Ringpu Bio-Technology Co.Ltd(300119) . SZ) said on the investor interaction platform on March 29 that the company invested 152 million yuan in R & D in 2021, accounting for 7.55% of the operating revenue. The company has always been committed to the independent research and development of animal health products such as poultry, livestock, waterfowl, aquatic products and pets. Based on several innovative animal protection product R & D platforms built by the company for many years, the company made a breakthrough in the independent R & D of new products in 2021. Focusing on key technologies, the company obtained 4 new veterinary drug registration certificates, 81 veterinary drug product approval numbers Feed additives and additive premixed feed products added 26 records, obtained 45 patent authorizations, and made important progress in several products under research of poultry, livestock and pets. See the 2021 annual report disclosed by the company for details.
